Bon Secours nears majority stake deal for Surgery Partners
Not-for-profit hospital operators in the U.S. are pushing deeper into outpatient care through larger acquisitions. Bon Secours Mercy Health is nearing a deal to buy a majority stake in Surgery Partners that would value the surgical care provider at roughly $6 billion including debt.
Highlights
- Bon Secours is in late-stage talks to acquire a majority stake in Surgery Partners for about $20 per share, valuing the company at roughly $6 billion enterprise value.
- Bain Capital will retain its nearly 40% stake in Surgery Partners, following over a year of unsuccessful sale attempts and after last year's abandoned go-private effort at a higher valuation.
- An acquisition would accelerate Bon Secours' outpatient care expansion, adding Surgery Partners' 176 surgery centres and hospitals, mirroring sector moves like Ascension's $3.9 billion Amsurg deal.
Deal structure and valuation
As reported by the Financial Times, Bon Secours is in late-stage talks to acquire a majority stake in Bain-backed Surgery Partners at about $20 a share, according to people familiar with the matter. The proposed take-private transaction would value the company at roughly $6 billion on an enterprise basis, including its $3.5 billion debt load, and could be announced as soon as Monday.Bain Capital, which has held a minority investment in Surgery Partners since 2017, is set to retain its nearly 40% stake as part of the deal. A sale would end more than a year of uneven efforts to sell the company after Bain abandoned a go-private attempt last year at a higher valuation.
Surgery Partners' shares are down 31% over the past year to just under $16, giving the group an equity value of nearly $2.1 billion. Bon Secours, Bain and Surgery Partners do not immediately respond to requests for comment.
Outpatient expansion and sector implications
An acquisition would materially speed up Bon Secours' expansion into outpatient care, an area drawing increased interest from hospital operators looking to broaden services beyond traditional inpatient settings. Surgery Partners operates 176 surgery centres and hospitals across 30 U.S. states, giving the buyer a sizeable national footprint.The talks also fit a broader pattern among not-for-profit healthcare providers pursuing large-scale transactions. Earlier this year, Ascension, another Catholic non-profit, agreed to buy surgery care provider Amsurg for $3.9 billion in a similar move into the outpatient segment.
Bon Secours runs 47 hospitals across the U.S. and Ireland and generates about $14 billion in revenue last year. The group also has recent dealmaking momentum after healthcare payment software specialist Ensemble, in which Bon Secours has invested since 2016, agreed earlier this year to sell a majority stake to Thoreau Group at an $11.75 billion valuation, while Bon Secours keeps a minority holding.
In our earlier article on EQT’s acquisition of Stockbridge, we examined how private capital managers are using M&A to build larger, more diversified platforms as fundraising pressure rises and exits remain challenging. We also noted that this consolidation trend is pushing major firms to buy rivals and expand into new strategies to stay competitive in a slower deal environment.